Professor Glenda Halliday, Senior Principal Research Fellow (Honorary) is an Australian Professor of neuroscience leading researchers tackling non-Alzheimers neurodegeneration that stems from her work on frontotemporal and motor neurodegenerative syndromes, and Parkinsons disease. Prof Halliday received her degrees at the University of New South Wales and postdoctoral training at Flinders University. She has been a Research Fellow in the National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) systems since 1988, working mainly at UNSW/NeuRA and the University of Sydney.  She was previously elected president of the Australian Neuroscience Society (ANS 2006-2007), on NHMRC Academy, ARC College of Experts, chaired and participated annually in NHMRC review panels, was secretary of Asia-Pacific Regional and Membership and Partnerships Committees of Int Brain Research Organization UNESCO (2008-16) and Director of the Sydney Brain Bank at NeuRA (2008-2016). She has had long associations with support groups for many neurodegenerative disorders, including Parkinsons NSW (1989-2016), US Alzheimers Association (2008-16), US Multiple System Atrophy Coalition (2018-2022), Defeat MSA (2020-) and Shake-it-up Australia (2011-)  She is a member of the NHMRC Research Committee (2022-4).

Prof Halliday has shaped international standards for the neuropathological diagnosis of neurodegenerative diseases, particularly Lewy body diseases and frontotemporal dementias, changing the way clinicians diagnose these disorders (received the 2017 David Marsden Lecture Award from International Parkinson and Movement Disorder Society and the 2021 Robert A. Pritzker Prize for Leadership in Parkinson's Research by the MJ Fox Foundation). She has made fundamental new discoveries of their underlying disease mechanisms, receiving the 2016 Cozzarelli Prize for outstanding paper from National Academy of Sciences USA. In the last decade, her expertise has been used on the organizing committees for all major international conferences in her field, as well as on scientific and editorial advisory boards (9 current editorial boards including Acta Neuropathologica and Science Advances).

Her research contributions have been recognised by the 2011 ANS Nina Kondelos Prize, being named as a NHMRC high achiever (2013), the NHMRC Elizabeth Blackburn awardee for leadership in clinical medicine and science (2015 & 2020), Fellowship of the Australian Academy of Health and Medical Sciences (2014) and the Australian Academy of Science (2021), and a Highly Cited Researcher by Clarivate Analytics (2018 on, >77,000 citations, >15% increase/y). In 2022 she received the NSW Scientist of the Year in the NSW Premiers Prizes for Science and Innovation awards.